Results 211 to 220 of about 7,898,890 (358)
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Advancing adolescent health promotion in the digital era. [PDF]
Raeside R.
europepmc +1 more source
Approach to the development of effective educational method for health promotion.
Shigeo Hinohara
openalex +2 more sources
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
The Impact of Hospital Volunteers' Health Promotion Programs on Health Literacy and Quality of Life. [PDF]
Chen CH, Loke SS, Han PC, Chen WC.
europepmc +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Stakeholders' perceptions on the role of professional sports clubs in local community health promotion. [PDF]
Brazier J+3 more
europepmc +1 more source
Implementation of the Henry J. Kaiser Family Foundation's Community Health Promotion Grant Program: A Process Evaluation [PDF]
Thomas M. Wickizer+10 more
openalex +1 more source